Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Total Current Liabilities (2022 - 2025)

NewGenIvf (NIVF) has disclosed Total Current Liabilities for 4 consecutive years, with $2.4 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 13.01% to $2.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Dec 2025, down 13.01% year-over-year, with the annual reading at $2.4 million for FY2025, 13.01% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $2.4 million at NewGenIvf, down from $2.7 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $2.7 million in Q4 2024, with the low at $1.1 million in Q4 2023.
  • Average Total Current Liabilities over 4 years is $2.2 million, with a median of $2.5 million recorded in 2022.
  • The sharpest move saw Total Current Liabilities tumbled 56.08% in 2023, then surged 142.36% in 2024.
  • Over 4 years, Total Current Liabilities stood at $2.6 million in 2022, then crashed by 56.08% to $1.1 million in 2023, then soared by 142.36% to $2.7 million in 2024, then fell by 13.01% to $2.4 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $2.4 million, $2.7 million, and $1.1 million for Q4 2025, Q4 2024, and Q4 2023 respectively.